Vishat Diagnostics receives ICMR nod for COVID-19 antigen kit

New Delhi: Mumbai-based Vishat Diagnostic said on Friday that it has received approval from Indian Council of Medical Research (ICMR) for supplying rapid testing antigen kit developed by Coris BioConcept.

The kit named COVID-19 Ag Respi-Strip works with both oral and nasal swabs and can show results in a short span of 15 minutes, stated in a release.

The company plans to launch the antigen testing kit at Rs 425.

“With COVID-19 Ag Respi-Strip, we are bringing CE certified and ICMR approved kits at affordable prices. We hope that it will help various state governments to fast pace the testing and isolation process,” said Pratik Chaitala, Managing Director, Vishat Diagnostics.

At a time when India is touching its peak in daily numbers of cases, it becomes critical to rapidly increase testing, he added.


The kit has been developed by Belgium-based firm Coris BioConcept, and is used in several European countries and in North America, it added.